Matrix Private Capital Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Matrix Private Capital Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,940	Closed	-$228K	–	193
2022 Q3	$228K	Sell	6,940 -2,173	-24%	-$79.8K	0.15%	113
2022 Q2	$287K	Sell	9,113 -4,047	-31%	-$142K	0.16%	113
2022 Q1	$604K	Sell	13,160 -368	-3%	-$17.5K	0.29%	71
2021 Q4	$828K	Sell	13,528 -7,265	-35%	-$502K	0.39%	59
2021 Q3	$1.55M	Buy	20,793 +920	+5%	+$77.2K	0.82%	28
2021 Q2	$1.84M	Buy	19,873 +999	+5%	+$84.9K	1.01%	21
2021 Q1	$1.68M	Buy	18,874 +14,044	+291%	+$1.39M	1.01%	19
2020 Q4	$450K	Buy	+4,830	New	+$385K	0.32%	79

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Matrix Private Capital Group's ARKG Position: Q4 2022 in Review

Matrix Private Capital Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 6,940 shares — an estimated $228K sold.

Matrix Private Capital Group first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $1.84M in Q2 2021. 319 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Matrix Private Capital Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
Matrix Private Capital Group sold 6,940 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $228K.
Matrix Private Capital Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
Matrix Private Capital Group's ARK Genomic Revolution ETF position peaked at $1.84M in Q2 2021.
319 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Matrix Private Capital Group's 13F filing for Q4 2022, filed 14 Feb 2023.